-
Views
-
Cite
Cite
Nassim Kamar, Lionel Rostaing, Florence Abravanel, Cyril Garrouste, Laure Esposito, Isabelle Cardeau-Desangles, Jean Michel Mansuy, Janick Selves, Jean Marie Peron, Philippe Otal, Fabrice Muscari, Jacques Izopet, Pegylated Interferon-α for Treating Chronic Hepatitis E Virus Infection after Liver Transplantation, Clinical Infectious Diseases, Volume 50, Issue 5, 1 March 2010, Pages e30–e33, https://doi.org/10.1086/650488
- Share Icon Share
Abstract
This study assessed the effect of a 3-month course of pegylated interferon-α-2a (Peg-IFN-α-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after Peg-IFN-α-2a therapy was completed. A relapse was observed in the third patient.
© 2010 by the Infectious Diseases Society of America
You do not currently have access to this article.